Telix gets the nod for phase two leukemia study

MELBOURNE: Pharmaceuticals developer Telix has been given the green light to launch a ... read more

Osprey trims losses 12 per cent to $US6.5M

MELBOURNE: Medtech Osprey has unveiled half-year revenues up by one third to $US1.1 ... read more

Fisher and Paykel Healthcare revenue edged back from Covid highs

AUCKLAND: Fisher and Paykel Healthcare said its revenue edged back by 2 per ... read more

Ebos Group Limited (NZX: EBO) full year results revealed

WELLINGTON: EBOS Group Limited today announced another record result for the 2021 financial ... read more